Subject(s)
Endocrine Disruptors/pharmacology , Evidence-Based Medicine , Legislation as Topic , Risk Assessment/methods , Terminology as Topic , Animals , Dose-Response Relationship, Drug , Endocrine Disruptors/toxicity , Endocrine System/drug effects , Environmental Pollutants/toxicity , European Union , Food Contamination/legislation & jurisprudence , Food Contamination/prevention & control , Government Agencies , Humans , Mutagens/pharmacology , Mutagens/toxicity , Periodicals as Topic , Pharmacology/legislation & jurisprudence , Pharmacology/methods , Publishing , Risk Assessment/legislation & jurisprudence , Toxicity Tests/standards , Toxicology/legislation & jurisprudence , Toxicology/methods , WorkforceSubject(s)
Advisory Committees , Endocrine Disruptors/standards , Endocrine Disruptors/toxicity , Animals , Ecotoxicology , Europe , Expert Testimony , Humans , Risk Assessment , ToxicologySubject(s)
Endocrine Disruptors/toxicity , Animals , Europe , Government Regulation , Humans , Risk AssessmentABSTRACT
Beside the production of complete immunoglobulins IgG, IgE, IgA, IgM and IgD, consisting of tetrameric heterodimers of immunoglobulin heavy and light chains, B cells also secrete immunoglobulin free light chains (Ig-fLC). Previous studies showed that Ig-fLCs are able to induce immediate hypersensitivity reactions. It is apparent that recognition and binding of antigen are crucial steps in the onset of these inflammatory responses. In this study, the binding characteristics of Ig-fLC to antigen were further investigated using various biochemical approaches. In addition, we investigated whether antigen-mediated crosslinking of Ig-fLC is required to initiate allergic skin inflammation in vivo. Our study shows that binding of Ig-fLCs to antigen can be measured with different experimental setups. Surface plasmon resonance analysis showed real-time antigen binding characteristics. Specific antigen binding by Ig-fLCs was further detected using immunoblotting and ELISA. Using the ELISA-based assay, a binding affinity of 76.9±3.8 nM was determined for TNP-specific Ig-fLC. Antigen-induced ear swelling in mice passively sensitized with trinitrophenol-specific Ig-fLC was inhibited when multivalent antigen was combined with excess of monovalent antigen during challenge. We conclude that Ig-fLCs are able to interact with antigen, a prerequisite for antigen-specific cellular activation. In analogy to antigen-specific Fc receptor-induced mast cell activation, crosslinking of Ig-fLCs is necessary to initiate a local allergic response.
Subject(s)
Antigens/immunology , Hypersensitivity/immunology , Immunoglobulin Light Chains/immunology , Animals , Antigens/metabolism , Hypersensitivity/metabolism , Immunoglobulin Light Chains/metabolism , Male , Mast Cells/immunology , Mast Cells/metabolism , Mice , Protein Binding , Skin/immunology , Skin/pathology , Surface Plasmon Resonance/methodsABSTRACT
UNLABELLED: Tobacco smoke is the main factor in the etiology of lung emphysema. Generally prolonged, substantial exposure is required to develop the disease. Humic acid is a major component of cigarette smoke that accumulates in smokers' lungs over time and induces tissue damage. OBJECTIVES: To investigate whether humic acid pre-loading potentiates the development of cigarette smoke-induced lung emphysema in mice and increases IL-8 release by human monocytes. METHODS: C57BL/6J mice received humic acid or aqueous vehicle by tracheal installation on day 0 and day 7. From day 21 to day 84, the mice were exposed to cigarette smoke or clean air for 5 days/week. Twenty-four hours after the last exposure we determined leukocytes in lung lavage, heart hypertrophy and alveolar wall destruction. Human monocytes were incubated with cigarette smoke extract (CSE), humic acid or the combination overnight. RESULTS: Humic acid nor cigarette smoke caused alveolar wall destruction within two months. Interestingly, the combination did induce lung emphysema. Humic acid, cigarette smoke or the combination did not change leukocyte types and numbers in lung lavage fluid, but the combination caused peribronchiolar and perivascular lymphocyte infiltration. Humic acid treatment resulted in a high proportion of alveolar macrophages heavily loaded with intracellular granula. Humic acid also induces the release of IL-8 from human monocytes and enhances the CSE-induced IL-8 release. CONCLUSIONS: Humic acid deposition in the lungs potentiates the development of cigarette smoke-induced interstitial inflammation and lung emphysema. Moreover, humic acid promotes IL-8 release from human monocytes. Since humic acid accumulates steadily in the lungs of smokers, this may provide an explanation for the natural history on late onset of this disease. The model described here offers a novel way to study emphysema and may direct the search for new therapeutic approaches.
Subject(s)
Humic Substances/toxicity , Interleukin-8/metabolism , Monocytes/drug effects , Nicotiana/adverse effects , Pulmonary Emphysema/etiology , Smoke/adverse effects , Animals , Female , Heart Defects, Congenital/etiology , Heart Ventricles/abnormalities , Lung/pathology , Mice , Mice, Inbred C57BL , Monocytes/immunology , Pulmonary Emphysema/pathology , Reactive Oxygen SpeciesABSTRACT
Chronic inflammation in lung diseases contributes to lung tissue destruction leading to the formation of chemotactic collagen fragments such as N-acetylated Proline-Glycine-Proline (N-ac-PGP). In this study, we investigated in more detail the mechanism of action of N-ac-PGP in neutrophilic inflammation. N-ac-PGP was chemotactic for human neutrophils via pertussis toxin sensitive G protein-coupled receptors in vitro and directly activated this cell type, which led to cytosolic calcium mobilization and release of CXCL8. Furthermore, using a selective CXCR2 antagonist confirmed that N-ac-PGP-induced neutrophil chemotaxis is mediated through CXCR2 activation. To determine whether N-ac-PGP was solely responsible for the migration and activation of human neutrophils in vitro and not the released CXCL8 upon stimulation with N-ac-PGP, an antibody directed against CXCL8 was used. Performing chemotaxis and calcium influx assays in the presence of this antibody did not alter the effects of N-ac-PGP whereas effects of CXCL8 were attenuated. These experiments indicate that N-ac-PGP, in addition to the direct induction of chemotaxis, also directly activates neutrophils to release CXCL8. In vivo, this may lead in the long term to a self-maintaining situation enhanced by both N-ac-PGP and CXCL8, leading to a further increase in neutrophil infiltration and chronic inflammation.
Subject(s)
Chemotaxis, Leukocyte/drug effects , Heterotrimeric GTP-Binding Proteins/metabolism , Interleukin-8/metabolism , Neutrophils/cytology , Neutrophils/drug effects , Oligopeptides/pharmacology , Antibodies/immunology , Calcium/metabolism , Collagen/metabolism , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Interleukin-8/antagonists & inhibitors , Interleukin-8/immunology , Neutrophils/metabolism , Peptide Fragments/pharmacology , Pertussis Toxin/toxicity , Receptors, G-Protein-Coupled/metabolism , Receptors, Interleukin-8B/metabolismABSTRACT
There is increasing evidence that the neutrophil chemoattractant proline-glycine-proline (PGP), derived from the breakdown of the extracellular matrix, plays an important role in neutrophil recruitment to the lung. PGP formation is a multistep process involving neutrophils, metalloproteinases (MMPs), and prolyl endopeptidase (PE). This cascade of events is now investigated in the development of lung emphysema. A/J mice were whole body exposed to cigarette smoke for 20 wk. After 20 wk or 8 wk after smoking cessation, animals were killed, and bronchoalveolar lavage fluid and lung tissue were collected to analyze the neutrophilic airway inflammation, the MMP-8 and MMP-9 levels, the PE activity, and the PGP levels. Lung tissue degradation was assessed by measuring the mean linear intercept. Additionally, we investigated the effect of the peptide L-arginine-threonine-arginine (RTR), which binds to PGP sequences, on the smoke-induced neutrophil influx in the lung after 5 days of smoke exposure. Neutrophilic airway inflammation was induced by cigarette smoke exposure. MMP-8 and MMP-9 levels, PE activity, and PGP levels were elevated in the lungs of cigarette smoke-exposed mice. PE was highly expressed in epithelial and inflammatory cells (macrophages and neutrophils) in lung tissue of cigarette smoke-exposed mice. After smoking cessation, the neutrophil influx, the MMP-8 and MMP-9 levels, the PE activity, and the PGP levels were decreased or reduced to normal levels. Moreover, RTR inhibited the smoke-induced neutrophil influx in the lung after 5 days' smoke exposure. In the present murine model of cigarette smoke-induced lung emphysema, it is demonstrated for the first time that all relevant components (neutrophils, MMP-8, MMP-9, PE) involved in PGP formation from collagen are upregulated in the airways. Together with MMPs, PE may play an important role in the formation of PGP and thus in the pathophysiology of lung emphysema.
Subject(s)
Collagen/metabolism , Nicotiana/toxicity , Pulmonary Emphysema/etiology , Pulmonary Emphysema/metabolism , Serine Endopeptidases/metabolism , Smoke/adverse effects , Animals , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Disease Models, Animal , Female , Lung/metabolism , Lung/pathology , Male , Matrix Metalloproteinase 8/metabolism , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred A , Mice, Inbred BALB C , Neutrophils/drug effects , Neutrophils/pathology , Oligopeptides/metabolism , Oligopeptides/pharmacology , Proline/analogs & derivatives , Proline/metabolism , Prolyl Oligopeptidases , Pulmonary Emphysema/pathology , Smoking/adverse effectsABSTRACT
BACKGROUND: Tobacco smoking irritates and damages the respiratory tract and contributes to a higher risk of developing lung emphysema. At present, smoking cessation is the only effective treatment for reducing the progression of lung emphysema, however, there is hardly anything known about the effects of smoking cessation on cytokine and chemokine levels in the airways. To the best of our knowledge, this is the first reported in vivo study in which cytokine profiles were determined after cessation of cigarette smoke exposure. METHODS: The severity of airway remodeling and inflammation was studied by analyzing alveolar enlargement, heart hypertrophy, inflammatory cells in the bronchoalveolar lavage fluid (BALF) and lung tissue and by determining the cytokine and chemokine profiles in the BALF of A/J mice exposed to cigarette smoke for 20 weeks and 8 weeks after smoking cessation. RESULTS: The alveolar enlargement and right ventricle heart hypertrophy found in smoke-exposed mice remained unchanged after smoking cessation. Although the neutrophilic inflammation in the BALF of cigarette smoke-exposed animals was reduced after smoking cessation, a sustained inflammation in the lung tissue was observed. The elevated cytokine (IL-1 alpha and TNF-alpha) and chemokine (CCL2 and CCL3) levels in the BALF of smoke-exposed mice returned to basal levels after smoking cessation, while the increased IL-12 levels did not return to its basal level. The cigarette smoke-enhanced VEGF levels did not significantly change after smoking cessation. Moreover, IL-10 levels were reduced in the BALF of smoke-exposed mice and these levels were still significantly decreased after smoking cessation compared to the control animals. CONCLUSION: The inflammatory changes in the airways caused by cigarette smoke exposure were only partially reversed after smoking cessation. Although smoking cessation should be the first step in reducing the progression of lung emphysema, additional medication could be provided to tackle the sustained airway inflammation.
Subject(s)
Airway Remodeling , Inflammation Mediators/metabolism , Lung/immunology , Pneumonia/immunology , Smoking Cessation , Smoking/adverse effects , Animals , Bronchoalveolar Lavage Fluid/immunology , Chemokine CCL2/metabolism , Chemokine CCL3/metabolism , Disease Models, Animal , Female , Hypertrophy, Right Ventricular/immunology , Hypertrophy, Right Ventricular/pathology , Interleukin-1alpha/metabolism , Lung/pathology , Lung Volume Measurements , Mice , Pneumonia/pathology , Pulmonary Alveoli/immunology , Pulmonary Alveoli/pathology , Severity of Illness Index , Time Factors , Tumor Necrosis Factor-alpha/metabolismABSTRACT
Traditionally, mast cells were regarded as key cells orchestrating type I hypersensitivity responses. However, it is now recognized that mast cells are widely involved in nonallergic (non-IgE) chronic diseases. Also, in inflammatory bowel disease (IBD), a disease not associated with increased IgE concentrations, clear signs of activation of mast cells have been found. In this study, we investigated if Ig-free L chain-induced hypersensitivity-like responses through activation of mast cells could contribute to the pathophysiology of IBD. As a mast cell-dependent model for IBD, mice were skin-sensitized with dinitrofluorobenzene followed by intrarectal application of the hapten. In this murine IBD model, F991 prevented mast cell activation and also abrogated the development of diarrhea, cellular infiltration, and colonic lymphoid follicle hyperplasia. Furthermore, passive immunization with Ag-specific Ig-free L chains (IgLCs) and subsequent rectal hapten challenge elicited local mast cell activation and increased vascular permeability in the colon of mice. Clinical support is provided by the observation that serum concentrations of IgLCs of patients suffering from Crohn's disease are greatly increased. Moreover, increased presence of IgLCs was evident in tissue specimens from colon and ileum tissue of patients with IBD. Our data suggest that IgLCs may play a role in the pathogenesis of IBD, which provides novel therapeutic means to prevent or ameliorate the adverse gastrointestinal manifestations of IBD.
Subject(s)
Colitis/immunology , Colitis/metabolism , Immunoglobulin kappa-Chains/physiology , Immunoglobulin lambda-Chains/physiology , Inflammatory Bowel Diseases/immunology , Inflammatory Bowel Diseases/metabolism , Mast Cells/immunology , Mast Cells/metabolism , Adult , Animals , Colitis/pathology , Crohn Disease/immunology , Crohn Disease/metabolism , Crohn Disease/pathology , Disease Models, Animal , Female , Humans , Immunization, Passive , Immunoglobulin kappa-Chains/biosynthesis , Immunoglobulin kappa-Chains/blood , Immunoglobulin lambda-Chains/biosynthesis , Immunoglobulin lambda-Chains/blood , Inflammatory Bowel Diseases/pathology , Male , Mast Cells/pathology , Mice , Mice, Inbred BALB C , Middle Aged , Up-Regulation/immunology , Young AdultABSTRACT
Extracellular ATP is a signalling molecule that often serves as a danger signal to alert the immune system of tissue damage. This molecule activates P2 nucleotide receptors, that include the ionotropic P2X receptors and the metabotropic P2Y receptors. Several publications highlight the importance of purinergic signalling in the pathogenesis of chronic airway inflammation. Recently, it has been reported that ATP accumulates in the airways of both animal models and patients with asthma or chronic obstructive pulmonary diseases (COPD); however, the role and function of ATP in the diseases process of COPD are not well understood. In this perspective, a brief overview is given on the role of ATP and P2 receptors in the pathogenesis of lung emphysema and COPD with a focus on neutrophils as messengers in intercellular communication between epithelial cells and macrophages and the activation of inflammasome pathways. Finding the link between purinergic signalling with inflammasome pathways will be a challenge for the future and could lead to the discovery of new therapeutic drugs for suppressing inflammation in the lungs of COPD patients.
Subject(s)
Adenosine Triphosphate/metabolism , Pulmonary Disease, Chronic Obstructive/metabolism , Signal Transduction/immunology , Humans , Inflammation/immunology , Inflammation/metabolism , Models, Biological , Neutrophils/immunology , Pulmonary Disease, Chronic Obstructive/etiology , Pulmonary Disease, Chronic Obstructive/immunology , Receptors, Purinergic P2/metabolismABSTRACT
Macrophages are key inflammatory cells in chronic obstructive pulmonary disease (COPD). The pathophysiology of cigarette smoke-induced lung emphysema is complex but there is a clear role for reactive oxygen species (ROS, such as peroxynitrite), tumor necrosis factor (TNF-alpha) and interleukin (IL)-8. We investigated whether TNF-alpha or cigarette smoke medium (CSM) alone or in combination induces the production of IL-8 by human macrophages or monocyte lymphoma U937. CSM and TNF-alpha induce a dose- and time-dependent increase in IL-8 production. Interestingly, when sub-threshold concentrations of CSM and TNF-alpha were co-incubated, a 1500% increase in IL-8 production was observed compared to either of the compounds alone. Similar results were obtained with TNF-alpha and the peroxynitrite donor SIN-1. Moreover, the overproduction of IL-8 was associated with an enhanced increase in the translocation of NF-kappaB and an enhanced decrease in glutathione levels. Preincubation of the cells with antioxidants, such as N-acetyl-L-cysteine (NAC), prevented the overproduction of IL-8 and activation of NF-kappaB. In conclusion, CSM exposure of macrophages up-regulates the expression and the production of IL-8 via reactive oxygen species and NF-kappaB activation. Moreover, CSM dramatically enhances the production of IL-8 in combination with TNF-alpha. Based upon the strong synergistic action, a combination therapy directed against ROS and TNF-alpha could be a new approach to stop the progression in lung damage during emphysema.
Subject(s)
Interleukin-8/metabolism , Macrophages/drug effects , Smoke/adverse effects , Tumor Necrosis Factor-alpha/pharmacology , Antioxidants/pharmacology , Cell Line, Tumor , Dose-Response Relationship, Drug , Drug Antagonism , Drug Combinations , Drug Synergism , Emphysema/drug therapy , Emphysema/metabolism , Glutathione , Humans , Macrophages/metabolism , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , NF-kappa B/biosynthesis , Nitric Oxide Donors/pharmacology , Reactive Oxygen Species/metabolism , Time Factors , Up-Regulation/drug effectsABSTRACT
Hypoallergenic milk formulae are used for cow's milk allergic infants and may be a good option for infants at risk. Clinical studies have shown that the protein source or the hydrolysis methodology used may influence the effectiveness in infants stressing the importance of adequate pre-clinical testing of hypoallergenic formulae in an in vivo model of orally induced cow's milk allergy. This study was undertaken to introduce a new read-out system to measure the residual allergenicity of whey hydrolysates on both the sensitization and challenge phase of orally induced cow's milk allergy in mice. Mice were sensitized orally to whey or a partial whey hydrolysate (pWH) to measure the residual sensitizing capacity. To predict the residual allergenicity of hydrolysates, whey allergic mice were challenged in the ear with pWH, extensive whey hydrolysate or an amino acid-based formula. An acute allergic skin response (ear swelling at 1 h), whey-specific serum antibodies, and local MCP-1 concentrations were measured. In contrast to whey, oral sensitization with pWH did not result in the induction of whey-specific antibodies, although a minor residual skin response to whey was observed after challenge. Skin exposure to whey hydrolysates showed a hydrolysation dependent reduction of the acute allergic skin response in whey allergic mice. In contrast to whey, skin exposure to pWH did not enhance tissue MCP-1 levels. The acute allergic skin response in mice orally sensitized to cow's milk proteins reveals a new pre-clinical tool which might provide information about the residual sensitizing capacity of hydrolysates supporting the discussion on the use of hypoallergenic formulae in high risk children. This mouse model might be a relevant model for the screening of new hypoallergenic formulae aimed to prevent or treat cow's milk allergy.
Subject(s)
Allergens/immunology , Milk Hypersensitivity/immunology , Milk Proteins/immunology , Protein Hydrolysates/immunology , Skin/drug effects , Acute Disease , Administration, Oral , Allergens/administration & dosage , Animals , Antibodies/blood , Cattle , Chemokine CCL2/metabolism , Disease Models, Animal , Female , Humans , Infant Formula/administration & dosage , Mice , Mice, Inbred C3H , Milk Hypersensitivity/blood , Milk Proteins/administration & dosage , Protein Hydrolysates/administration & dosage , Skin/pathology , Whey ProteinsABSTRACT
Nonsteroidal anti-inflammatory drugs (NSAIDs) are major drugs used in the treatment of inflammation and pain in a wide variety of disorders. The best-known mechanism of action of NSAIDs is the inhibition of prostaglandin synthesis as a result of their action on cyclooxygenase (COX) enzymes. However, data have been accumulating through the years indicating that NSAIDs also act on other targets in cell signaling. It has been established that NSAIDs induce anti-inflammatory effects independent of COX. Acetylsalicylic acid (ASA) and other inhibitors of COX induce severe bronchospasms and asthmatic attacks in a significant population of asthmatic patients. The etiology of ASA induced asthma is complex and not fully understood, but most evidence points towards an abnormality of arachidonic acid (AA) metabolism. Since doses of ASA necessary to treat chronic inflammatory diseases appeared much higher than those required to inhibit PG synthesis, COX-independent mechanisms of NSAIDs were postulated. Recently, we have shown that NSAIDs induced expression of heat shock proteins specially HSP70. Heat shock proteins (HSPs) are normal intracellular proteins that are produced in greater amounts when cells are subjected to stress or injury. Interestingly, a potential pathogenic role for heat shock proteins in diseases such as autoimmune disease, vascular disease has been reported. Because mast cells have been reported to play a role in the pathogenesis of ASA induced asthma, a link between heat shock proteins and this disease could postulated. In this review, an overview is given on aspirin-induced asthma and the cells and mediators that may play a role therein. Mast cell signaling with regard to interaction with NSAIDs and heat shock proteins (HSPs) and toll-like receptors (TLRs) is further highlighted.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Aspirin/pharmacology , Asthma, Aspirin-Induced/immunology , Mast Cells/drug effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Arachidonic Acid/metabolism , Aspirin/adverse effects , Dinoprost/analogs & derivatives , Dinoprost/metabolism , HSP70 Heat-Shock Proteins/metabolism , Humans , Leukotrienes/metabolism , Mast Cells/immunology , Phosphoric Monoester Hydrolases/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Toll-Like Receptors/metabolismABSTRACT
Extracellular ATP is a signaling molecule that often serves as a danger signal to alert the immune system of tissue damage. This molecule activates P2 nucleotide receptors, that include the ionotropic P2X receptors and metabotropic P2Y receptors. Recently, it has been reported that ATP accumulates in the airways of both asthmatic patients and sensitized mice after allergen challenge. The role and function of ATP in the pathogenesis of chronic obstructive pulmonary diseases (COPD) are not well understood. In this study we investigated the effect of cigarette smoke on purinergic receptors and ATP release by neutrophils. Neutrophils and their mediators are key players in the pathogenesis of lung emphysema. Here we demonstrated that in an in vivo model of cigarette smoke-induced lung emphysema, the amount of ATP was increased in the bronchoalveolar lavage fluid. Moreover, activation of neutrophils with cigarette smoke extract induced ATP release. Treatment of neutrophils with apyrase (catalyses the hydrolysis of ATP to yield AMP) and suramin (P2-receptor antagonist) abrogated the release of CXCL8 and elastase induced by cigarette smoke extract and exogenous ATP. These observations indicate that activation of purinergic signaling by cigarette smoke may take part in the pathogenesis of lung emphysema.
Subject(s)
Adenosine Triphosphate/metabolism , Pulmonary Emphysema/metabolism , Pulmonary Emphysema/pathology , Animals , Apyrase/pharmacology , Bronchoalveolar Lavage Fluid , Humans , Interleukin-8/metabolism , Male , Mice , Mice, Inbred BALB C , Neutrophil Activation , Neutrophils/drug effects , Neutrophils/immunology , Pancreatic Elastase/metabolism , Pulmonary Emphysema/etiology , Pulmonary Emphysema/immunology , Signal Transduction , Smoking/adverse effects , Suramin/pharmacologyABSTRACT
Myeloid and plasmacytoid dendritic cells (mDCs, pDC) are crucial to the immune system, detecting microorganisms and linking the innate and adaptive immunity. pDC are present in small quantities in tissues that are in contact with the external environment; mainly the skin, the inner lining of the nose, lungs, stomach and intestines. They produce large amounts of IFN-alpha after stimulation and are pivotal for the induction of antiviral responses. Chronic obstructive pulmonary disease (COPD) patients are known to be more susceptible to viral infections. We have demonstrated that exposure of mDC to cigarette smoke extract (CSE) leads to the release of chemokines, however, not much is known about the role of pDC in COPD. In this study, we addressed several key questions with respect to the mechanism of action of CSE on human pDC in an in vitro model. Human pDCs were isolated from normal healthy volunteers and subjected to fresh CSE and the levels of IL-8, TNF-alpha, IP-10, IL-6, IL-1, IL-12 and IL-10 and IFN-alpha were studied by both ELISA and real time PCR methods. We observed that CSE augmented the production of IL-8 and suppressed the release of TNF-alpha, IL-6 and IFN-alpha. Moreover, CSE suppressed PI3K/Akt signalling in pDC. In conclusion, our data indicate that CSE has both the potential to diminish anti-viral immunity by downregulating the release of IFN-alpha and other pro-inflammatory cytokines while, at the same time, augmenting the pathogenesis of COPD via an IL-8 induced recruitment of neutrophils.